Linda J Kelly

Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective Modulator

Joel P. Berger, Ann Petro, Karen L. MacNaul et al. · Molecular Endocrinology · 2003 · 321 citations · Full text

Lipid Peroxidation, Molecular Biology, Redox Biology +17

Evidence-based consensus on the insertion of central venous access devices: definition of minimal requirements for training

Nancy Moureau, Massimo Lamperti, Linda J Kelly et al. · British Journal of Anaesthesia · 2013 · 221 citations · Full text

Venous Disease, Minimal Requirements, Evidence-based Consensus +7

Evidence for Peroxisome Proliferator-Activated Receptor (PPAR)α-Independent Peroxisome Proliferation: Effects of PPARγ/δ-Specific Agonists in PPARα-Null Mice

John G. DeLuca, Thomas W. Doebber, Linda J Kelly et al. · Molecular Pharmacology · 2000 · 53 citations

Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation

Olívia Wu, Kathleen Boyd, Elaine McCartney et al. · British Journal of Cancer · 2016 · 48 citations · Full text

A Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist Demonstrates Favorable Effects on Lipid Homeostasis

Qiu Guo, Soumya P. Sahoo, Pei-Ran Wang et al. · Endocrinology · 2004 · 40 citations · Full text